Chronic Liver Disease (CLD) - Causes, Symptoms, Treatment and Management

Fatty liver disease (NAFLD/MASLD)

Fat accumulation in the liver due to obesity, diabetes, high cholesterol, or metabolic syndrome; currently one of the most common causes.

Alcohol-related liver disease

Long-term excessive alcohol intake damages liver cells.

Hepatitis B

Chronic viral infection causing ongoing inflammation.

Hepatitis C

Chronic viral infection that may silently damage the liver for years.

Autoimmune hepatitis

The immune system attacks liver tissue.

Primary biliary cholangitis (PBC)

Autoimmune destruction of small bile ducts.

Primary sclerosing cholangitis (PSC)

Inflammation and narrowing of bile ducts.

Hemochromatosis

Excess iron deposition in the liver.

Wilson disease

Copper accumulation in the liver and other organs.

Alpha-1 antitrypsin deficiency

Inherited disorder causing liver injury.

Long-term drug or toxin exposure

Some medicines, herbal products, or toxins can injure the liver.

Chronic biliary obstruction

Long-standing blockage of bile flow.

Repeated liver infections or inflammation

Less common causes of chronic damage.

Fatty liver disease

Often none; fatigue, mild abdominal discomfort

Alcohol-related disease

Fatigue, appetite loss, jaundice, abdominal swelling

Hepatitis B/C

May remain silent for years; later fatigue and jaundice

PBC/PSC

Prominent itching and fatigue

Hemochromatosis

Fatigue, joint pain, skin darkening, diabetes

Wilson disease

Liver disease with neurological or psychiatric symptoms

Alcohol-related liver disease

Complete alcohol abstinence

Stops ongoing toxic injury from acetaldehyde and oxidative stress, allowing liver regeneration.

NAFLD/MASLD

Weight loss, exercise, control diabetes/lipids

Reduces hepatic fat, insulin resistance, inflammation, and fibrosis progression.

Hepatitis B

Tenofovir, Entecavir

Inhibit HBV DNA polymerase → suppress viral replication and liver inflammation.

Hepatitis C

Direct-acting antivirals (DAAs)

Block HCV proteins (NS3/4A, NS5A, NS5B) → eradicate virus.

Autoimmune hepatitis

Prednisolone ± Azathioprine

Suppress immune-mediated attack on hepatocytes.

PBC

Ursodeoxycholic acid (UDCA)

Improves bile flow and protects bile duct cells from toxic bile acids.

Wilson disease

Penicillamine / Trientine / Zinc

Chelate copper or reduce intestinal copper absorption.

Hemochromatosis

Phlebotomy

Removes excess iron stores, reducing oxidative liver injury.

Spironolactone

Aldosterone antagonist → increases sodium and water excretion.

Furosemide

Loop diuretic → blocks Na⁺/K⁺/2Cl⁻ transporter in loop of Henle.

Terlipressin

Splanchnic vasoconstriction → lowers portal pressure.

Octreotide

Somatostatin analogue → reduces splanchnic blood flow.

Endoscopic band ligation

Physically stops bleeding.

Antibiotics (e.g., ceftriaxone)

Prevent bacterial infections that worsen bleeding outcomes.

Cholestyramine

Binds bile acids in intestine, reducing circulating bile salts.

Rifampicin

Induces hepatic enzymes and alters pruritogen metabolism.

Tenofovir disoproxil fumarate (TDF)

Suppress HBV replication

Tenofovir alafenamide (TAF)

Suppress HBV replication with lower renal/bone exposure

Entecavir

Inhibit HBV DNA polymerase

Sofosbuvir + Velpatasvir

Viral eradication

Sofosbuvir + Ledipasvir

Viral eradication

Glecaprevir + Pibrentasvir

Viral eradication

Prednisolone

Reduce immune-mediated liver inflammation

Azathioprine

Maintenance immunosuppression

Budesonide (selected non-cirrhotic patients)

Alternative steroid with high first-pass hepatic effect

Ursodeoxycholic acid (UDCA / Ursodiol)

Improve bile flow; first-line in PBC

Obeticholic acid

Add-on therapy in selected PBC patients

Spironolactone

First-line diuretic in cirrhotic ascites

Furosemide

Add-on loop diuretic

Torsemide

Alternative loop diuretic

Human albumin infusion

Volume support after large-volume paracentesis

Propranolol

Primary and secondary prevention of variceal bleeding

Nadolol

Alternative non-selective beta blocker

Carvedilol

Commonly used in cirrhosis; reduces portal pressure

Terlipressin

Emergency control of variceal bleeding

Octreotide

Reduce splanchnic blood flow

Ceftriaxone

Prevent infection during bleeding episode

Lactulose

First-line ammonia-lowering therapy

Rifaximin

Add-on for recurrent encephalopathy

L-ornithine L-aspartate (LOLA)

Adjunctive ammonia-lowering agent

Cholestyramine

First-line bile acid binding resin

Rifampicin

Second-line therapy

Naltrexone

For refractory itching

Sertraline

Occasionally used in refractory pruritus

Terlipressin + Albumin

Standard therapy in many centres

Noradrenaline + Albumin

ICU alternative where terlipressin unavailable

Pioglitazone

Selected NASH patients, especially with diabetes

Semaglutide / Liraglutide

Weight loss and metabolic improvement

Vitamin E

Selected non-diabetic biopsy-proven NASH

1. Antiviral drugs for Chronic Hepatitis B

2. Direct-acting antivirals for Hepatitis C

3. Drugs for Autoimmune Hepatitis

4. Cholestatic Liver Disease (PBC/PSC)

5. Ascites (fluid accumulation)

6. Portal Hypertension / Variceal Bleed Prophylaxis

7. Acute Variceal Bleeding

8. Hepatic Encephalopathy

9. Cholestatic Pruritus

10. Hepatorenal Syndrome

11. Fatty Liver Disease (selected patients)

Key lifestyle changes

1. Completely avoid alcohol

• This is the single most important step, even if the liver disease is not caused by alcohol.
• Alcohol accelerates fibrosis and cirrhosis.

2. Maintain a healthy weight

• If overweight, aim for gradual weight loss (about 0.5–1 kg/week).
• A loss of 7–10% of body weight can improve fatty liver and inflammation.

3. Exercise regularly

Aim for:

• 150 minutes/week of brisk walking, cycling, or swimming, and
• 2 days/week of light strength training.

Exercise improves insulin sensitivity and reduces liver fat.

4. Eat a liver-friendly diet

Prefer:

• vegetables and fruits,
• whole grains,
• pulses, beans, and dals,
• lean protein (fish, egg white, chicken without skin, soy, paneer in moderation),
• healthy fats (nuts, seeds, olive/mustard oil).

Limit:

• fried foods,
• bakery items and trans fats,
• sugary drinks, sweets, and excess refined carbohydrates,
• processed meats.

5. Take adequate protein

Unless your doctor specifically restricts it, most CLD patients need 1.2–1.5 g/kg/day protein to prevent muscle loss.

Good protein sources: dal, milk, curd, paneer, eggs, fish, chicken, soy.

6. Reduce salt if swelling or ascites is present

• Target less than 2 g sodium/day (about 5 g salt/day).
• Avoid pickles, papad, chips, namkeen, packaged soups, sauces, and processed foods.

Important precautions

Medicines

• Do not self-medicate. Many drugs can harm the liver.
• Avoid unnecessary painkillers such as diclofenac, ibuprofen, naproxen unless prescribed.
• Paracetamol should be used only in recommended doses (often not more than 2 g/day in stable CLD unless your doctor advises otherwise).
• Avoid herbal “liver tonics” and supplements of unknown composition.
• Inform every doctor that you have chronic liver disease before starting any medicine.

Vaccination

Ask your doctor about vaccination against:

• Hepatitis A
• Hepatitis B
• Annual influenza
• Pneumococcal vaccine (in advanced liver disease)

Prevent infections

• Wash hands regularly.
• Drink clean water.
• Avoid raw or undercooked seafood and meat.
• Seek treatment early for fever, cough, burning urine, or diarrhoea.

Avoid smoking and tobacco

Smoking increases the risk of liver cancer and cardiovascular disease.

Daily habits that help

If you have cirrhosis or advanced liver disease

Watch for warning signs

Seek urgent medical care if you develop:

• vomiting blood,
• black stools,
• increasing abdominal swelling,
• yellowing of eyes worsening,
• confusion, excessive sleepiness, or personality changes,
• fever with abdominal pain,
• reduced urine output,
• sudden leg swelling.

Additional measures

• Weigh yourself daily; a rapid increase may mean fluid retention.
• Avoid constipation; take lactulose if prescribed.
• Do not drive if you are confused or drowsy.

Monitoring and follow-up

Regular follow-up with a gastroenterologist/hepatologist is essential.

Typical monitoring includes:

• liver function tests,
• INR and albumin,
• kidney function,
• ultrasound liver every 6 months,
• screening for oesophageal varices when advised.

Common supplements used in Chronic Liver Disease (India)

When these supplements are commonly used

Muscle loss / low protein

BCAA, hepatic protein powders

Help preserve muscle mass and improve nutritional status.

Hepatic encephalopathy

LOLA, BCAA, Zinc

Support ammonia metabolism and may reduce recurrence when used with standard therapy.

Alcohol-related liver disease

Thiamine, B-complex, folic acid

Correct common vitamin deficiencies caused by alcohol misuse.

Vitamin D deficiency / bone disease

Vitamin D3, Calcium + D3

Reduce risk of osteoporosis and fractures in chronic liver disease.

General malnutrition

Multivitamins, protein supplements

Improve overall nutritional intake when diet is inadequate.

Fatty liver / high triglycerides

Omega-3 fatty acids

May help lower triglycerides and improve fatty liver in selected patients.

Selected non-diabetic NASH

Vitamin E

Antioxidant therapy used in carefully selected patients under specialist advice.

Brief mechanism of action

Practical Indian prescription patterns

• Compensated cirrhosis with poor appetite: Prohance Hepatic + multivitamin.
• Alcoholic cirrhosis: Benadon + Becosules + folic acid.
• Recurrent encephalopathy: Lactulose + Rifaximin + Hepa-Merz ± Zincovit.
• Sarcopenia (muscle wasting): BCAA supplement + high-protein diet.
• Vitamin D deficiency: Uprise-D3 weekly for a prescribed duration, then maintenance.

Important precautions

Use supplements only after medical advice

Advanced liver disease changes nutrient handling; unnecessary supplements may be harmful.

• Avoid high-dose vitamin A and unnecessary herbal liver products.
• Iron should be taken only when iron deficiency is confirmed.
• Protein supplements may need adjustment in severe encephalopathy.
• Monitor vitamin D, calcium, zinc, and iron levels periodically when on long-term supplementation.
• Patients with kidney disease or ascites should not start supplements without supervision.

Most commonly recommended supplements in Indian hepatology practice

High-frequency use

Hepa-Merz (LOLA)

Prohance Hepatic / Resource Hepatic (hepatic nutrition)

Zincovit (zinc + multivitamins)

Benadon (thiamine)

Becosules (B-complex)

Uprise-D3 (vitamin D3)

Shelcal-500 (calcium + D3)

Aquecium D3 (Coral Calcium + D3) - GenLife